Stem cells have two unique properties that make them an appealing therapeutic tool for regenerative medicine: they can grow indefinitely and can differentiate into a wide variety of cell types, including those that form blood, bones, lungs, skin, and the brain.
As the pandemic persisted across the state, did Texans living in cities have better access to Covid-19 vaccines than those in rural areas? How did race or age factor in? The authors assess the successes and shortfalls of Texas' vaccine distribution strategy, and how to do better next time.
If the U.S. is to create a resilient energy supply chain and securitize its own needs for the energy transition, it should be more proactive in resource and supply chain development in Latin America. The author explains why.
Effective drug policy requires acceptance that, for better or worse, licit and illicit drug use is part of our world. The authors recommend several steps the federal government can take to facilitate more pragmatic and effective drug policy at all levels of government.
Katharine Neill Harris, William MartinFebruary 5, 2021
By Michael W. Deem, Melia E. Bonomo and Kirstin R.W. Matthews
Due to the rapidly mutating influenza virus, a new vaccine is usually developed for each flu season. In this policy brief, the authors discuss the current method used by the Centers for Disease Control and Prevention to develop the flu vaccine and propose the use of mathematical modeling to improve the vaccine's effectiveness.
Michael W. Deem, Melia E. Bonomo, Kirstin R.W. MatthewsOctober 29, 2018
Science, technology, and innovation are vital to America’s economy and workforce, and the competitiveness of U.S. industry. The authors offer five recommendations to ensure the establishment of an effective White House Office of Science and Technology Policy.
Kirstin R.W. Matthews, Kenneth M. Evans, Neal F. LaneDecember 5, 2016
There is broad consensus in the medical and scientific community that substance abuse should be treated as a medical and public health problem, not a crime. The authors recommend a sensible pivot from failed policies of drug prohibition toward a realistic approach to drug use.
William Martin, Katharine Neill HarrisDecember 5, 2016
This issue brief argues that continued investments in global health and the study of emerging pathogens could yield better tools to fight infectious diseases like the Zika virus long before they become a problem in the developed world.
Jennifer R. Herricks, Kirstin R.W. MatthewsMarch 4, 2016
This policy brief urges collaboration between the United States and Mexico to address widespread epidemics of mosquito-transmitted diseases like West Nile, dengue and chikungunya in both countries. Such policy development should focus on vector control programs, public awareness and the development of vaccines to curb the spread of these diseases.
Kirstin R.W. Matthews, Jennifer R. HerricksDecember 16, 2015
Officials in the U.S. and Mexico should coordinate a response to the spread of Chagas disease in their countries. Chagas is the third most common parasitic infection in the world.
Kirstin R.W. Matthews, Jennifer R. HerricksOctober 30, 2015